《Phys.org,1月11日,Catching the COVID wiggle: Researchers develop new way to visualize how the spike protein shows off its moves》

  • 来源专题:COVID-19科研动态监测
  • 编译者: YUTING
  • 发布时间:2022-01-25
  • Coronaviruses are slippery, and that makes it hard to create effective vaccines that provide long-term protection. Now, University of Connectiut (UConn) researchers have developed a new way to model the spike protein of the virus and test its binding to antibodies. That could give scientists a firmer grip on the virus that causes COVID-19.

    By now, the majority of adult citizens in the US have been vaccinated against COVID, and many have had booster shots as well. Despite this, about 30% of hospitalized COVID patients in Connecticut are fully vaccinated. Although there are several different COVID vaccines in use around the world, none of them provides long-term, durable protection against the virus.

    The problem is the coronavirus's spike protein. The spikes coat the virus, and are so wiggly and flexible that they slip through the clutches of antibodies like a weasel through a wedding ring. Without a firm grasp on the spike, the immune system cannot make good antibodies. And without good neutralizing antibodies, the immune system's memory of the virus is too fuzzy to last.

  • 原文来源:https://phys.org/news/2022-01-covid-wiggle-visualize-spike-protein.html
相关报告
  • 《Phys.org,1月18日,Researchers explore vulnerabilities within SARS-CoV-2 'hotbeds' of replication》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-02-08
    • Beneath the SARS-CoV-2 membrane and its spikes lurks a squiggle of genetic material, or RNA, enveloped by a protein that acts like bubble wrap to protect the genetic material. This protein also acts as a "hotbed" for multiple interactions to control the infected cell. Through atomic-resolution studies conducted by University of Colorado Anschutz Medical Campus researchers and others, how this protein interacts with its targets to regulate multiple functions, such as viral replication, is now becoming clearer. Getting at the root of SARS-CoV-2 infection—and searching for vulnerabilities to exploit therein, potentially to curb infections from more coronaviruses—is a research interest of Elan Eisenmesser, Ph.D., an associate professor in the Department of Biochemistry and Molecular Genetics at the University of Colorado School of Medicine. This "hotbed" of interactions sits on the nucleocapsid, one of four structural proteins encoded by SARS-CoV-2. The other three proteins are the spike, membrane and envelope proteins. The nucleocapsid is made up of 419 residues with distinct domains that include a well-folded N- and C-terminal domain. However, over half of the nucleocapsid protein (N protein) comprises largely dynamic, or flexible, regions made of spaghetti-like sections, referred to as "intrinsically disordered regions." Eisenmesser's team has been studying all of the regions of the nucleocapsid protein to better understand how N proteins play a role in packaging viral RNA and manipulating host cell machinery. Part of the nucleocapsid's manipulative behavior, Eisenmesser said, could be to prevent the host cell's ability to mount an immune response, basically by blocking proteins from carrying out their virus-fighting jobs.
  • 《Phys.org,2月21日,Why natural killer cells react to COVID-19》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-03-03
    • Little has been known to date about how the immune system's natural killer (NK) cells detect which cells have been infected with SARS-CoV-2. An international team of scientist led by researchers from Karolinska Institutet now shows that NK cells respond to a certain peptide on the surface of infected cells. The study, which is published in Cell Reports, is an important piece of the puzzle in our understanding of how the immune system reacts to COVID-19. NK cells are white blood cells that are part of the innate immune system. Unlike cells in the adaptive immune defense, they are able to recognize and kill cancer cells and virus-infected cells immediately without having encountered them before. This ability is controlled by a balance between the NK cells' activating and inhibiting receptors, which can react to different molecules on the surface of other cells. The virus is revealed by a peptide A new study shows why certain NK cells are activated when encountering a cell infected with SARS-CoV-2. The infected cells contain a peptide from the virus that triggers a reaction in NK cells that carry a particular receptor, NKG2A, able to detect the peptide. "Our study shows that SARS-CoV-2 contains a peptide that is displayed by molecules on the cell surface," says Quirin Hammer, researcher at the Center for Infectious Medicine (CIM), Karolinska Institutet. "The activation of NK cells is a complex reaction, and here the peptide blocks the inhibition of the NK cells, which allows them to be activated. This new knowledge is an important piece of the puzzle in our understanding of how our immune system reacts in the presence of this viral infection." The study was a major collaboration between Karolinska Institutet, Karolinska University Hospital and research laboratories and universities in Italy, Germany, Norway and the U.S. The first phase was to test their hypothesis using computer simulations that were then confirmed in the laboratory. The decisive phase was the infection of human lung cells with SARS-CoV-2 in a controlled environment, whereupon the researchers could show that NK cells with the receptor in question are activated to a greater degree than the NK cells without it.